Aristo Bio-Tech & Lifescience
ARISTO NSE
Aristo Bio-Tech & Lifescience
ChemicalsNSE: ARISTO Pesticides & Agrochemicals
Key Fundamentals
SMEPesticides & AgrochemicalsChemicalsMarket Cap
₹73.52 Cr
Volatility
Moderate
P/E Ratio
10.2
EBITDA
₹16.05 Cr
Return on Equity
10.88%
Debt to Equity
0.78
Book Value
₹65.39
52W High
₹140
52W Low
₹74.3
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has delivered good profit growth of 46.1% CAGR over last 5 years
Weaknesses
1- Company has a low return on equity of 13.9% over last 3 years.
Growth Rate
Revenue Growth
14.2% lower than
3Y
Net Income Growth
73.66% higher than
3Y
Cash Flow Change
31.84% lower than
3Y
ROE
-6.13% lower than
3Y
ROCE
-2.59% higher than
3Y
EBITDA Margin (Avg.)
44.59% higher than
3Y
Quarterly Results
| Particulars | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 129 | 89 | 133 | 112 | 214 | 104 | 256 | 107 |
| Expenses | 72 | 124 | 85 | 128 | 109 | 206 | 103 | 249 | 99 |
| Operating Profit | 1 | 5 | 4 | 5 | 3 | 8 | 1 | 8 | 8 |
| OPM % | 1.2% | 3.9% | 4.1% | 4% | 2.9% | 3.8% | 1.1% | 3.1% | 8% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | -1 | 4 | 1 | 4 | 2 | 6 | -1 | 6 | 4 |
| Tax % | -35% | 28% | 13% | 28% | 27% | 25% | -18% | 25% | 27% |
| Net Profit | 0 | 3 | 1 | 3 | 1 | 5 | 0 | 4 | 3 |
| EPS in Rs | -0.48 | 3.8 | 1.47 | 3.78 | 1.94 | 6.68 | -0.72 | 6.13 | 4.42 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57 | 159 | 271 | 202 | 201 | 167 | 166 | 218 | 245 | 318 | 364 |
| Expenses | 56 | 157 | 263 | 195 | 197 | 163 | 160 | 209 | 236 | 309 | 348 |
| Operating Profit | 1 | 3 | 7 | 7 | 5 | 4 | 5 | 9 | 8 | 9 | 16 |
| OPM % | 1.6% | 1.6% | 2.7% | 3.4% | 2.2% | 2.6% | 3.3% | 4% | 3.5% | 2.9% | 4.4% |
| Other Income | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| PBT | 1 | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 5 | 10 |
| Tax % | 33% | 31% | 34% | 31% | 28% | 28% | 28% | 25% | 28% | 26% | 26% |
| Net Profit | 0 | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 4 | 7 |
| EPS in Rs | 4 | 18.52 | 37.44 | 5.67 | 2.02 | 2.16 | 2.14 | 5.23 | 5.73 | 5.96 | 10.55 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 7% | 8% | 6% |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 |
| Reserves | 2 | 4 | 7 | 6 | 7 | 8 | 10 | 23 | 27 | 31 | 38 |
| Borrowings | 5 | 10 | 20 | 14 | 20 | 22 | 25 | 22 | 21 | 22 | 35 |
| Other Liabilities | 20 | 72 | 60 | 65 | 56 | 46 | 37 | 47 | 73 | 81 | 75 |
| Total Liabilities | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| Fixed Assets | 2 | 2 | 8 | 8 | 8 | 12 | 14 | 16 | 22 | 24 | 24 |
| CWIP | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 25 | 85 | 81 | 81 | 77 | 69 | 63 | 83 | 106 | 117 | 131 |
| Total Assets | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | 10 | 8 |
| Investing | — | 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | -5 | -3 |
| Financing | — | 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | -4 | -4 |
| Net Cash Flow | — | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 0 | 2 |
| Free Cash Flow | — | -4 | 0 | 6 | -1 | 0 | 4 | -7 | 1 | 5 | 5 |
| CFO/OP | — | -123 | 38 | 138 | 40 | 60 | 134 | -17 | 106 | 123 | 69 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 121 | 65 | 77 | 88 | 72 | 73 | 75 | 86 | 65 | 55 |
| Inventory Days | 66 | 67 | 42 | 65 | 47 | 78 | 60 | 57 | 65 | 59 | 70 |
| Days Payable | 142 | 177 | 85 | 124 | 74 | 93 | 87 | 85 | 112 | 97 | 78 |
| Cash Conversion Cycle | 16 | 11 | 23 | 18 | 61 | 56 | 46 | 48 | 38 | 26 | 46 |
| Working Capital Days | 3 | 14 | 14 | 15 | 20 | 28 | 25 | 37 | 31 | 22 | 25 |
| ROCE % | — | 31% | 34% | 24% | 14% | 11% | 12% | 16% | 13% | 12% | 20% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aristo Bio-Tech & Lifescience insights
57 extracted metrics + investor summaries across FY16–FY26.
Documents
1
Updates
11 Sep - 21st AGM on September 30, 2026; FY2025-26 annual report, e-voting dates announced. 11 Sep - 21st AGM on September 30, 2026; FY2025-26 annual report, e-voting dates announced.
2
Copy of Newspaper Publication
8 Sep - Newspaper advertisement for 21st AGM on September 30, 2026, via VC/OAVM with e-voting details. 8 Sep - Newspaper advertisement for 21st AGM on September 30, 2026, via VC/OAVM with e-voting details.
3
Shareholders meeting
8 Sep - 21st AGM on September 30, 2026; ₹0.60 final dividend proposed, record date September 23, 2026. 8 Sep - 21st AGM on September 30, 2026; ₹0.60 final dividend proposed, record date September 23, 2026.
4
Outcome of Board Meeting
7 Sep - Board approved reappointments, cost auditor, Rs.0.60 final dividend record date September 23, 2026, and AGM on September 30. 7 Sep - Board approved reappointments, cost auditor, Rs.0.60 final dividend record date September 23, 2026, and AGM on September 30.
5
Record Date
7 Sep - Board approved WTD and independent director reappointments, FY27 cost auditor, AGM on September 30, 2026, dividend record date September 23. 7 Sep - Board approved WTD and independent director reappointments, FY27 cost auditor, AGM on September 30, 2026, dividend record date September 23.
Frequently Asked Questions about Aristo Bio-Tech & Lifescience
What does Aristo Bio-Tech & Lifescience Ltd do?
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
Where is Aristo Bio-Tech & Lifescience Ltd (ARISTO) listed?
Aristo Bio-Tech & Lifescience Ltd trades as ARISTO on the NSE.
Which sector does Aristo Bio-Tech & Lifescience Ltd belong to?
Aristo Bio-Tech & Lifescience Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd has a market capitalisation of ₹73.52 Cr, which places it in the Small Cap band.
What is the PE ratio of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd trades at a PE ratio of 10.20, against a book value of ₹65.39 per share.
What is the 52-week high and low of Aristo Bio-Tech & Lifescience Ltd?
Over the last 52 weeks Aristo Bio-Tech & Lifescience Ltd has traded between ₹74.3 and ₹140.
Does Aristo Bio-Tech & Lifescience Ltd pay dividends?
Aristo Bio-Tech & Lifescience Ltd has a dividend yield of 0.46%.
What is the Return on Equity (ROE) of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd reported a return on equity of 10.88%. Its debt-to-equity ratio is 0.78.
Company Information
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ARISTO.md for Aristo Bio-Tech & Lifescience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.